Effects of soy components on blood and liver lipids in rats fed high-cholesterol diets

被引:31
作者
Lin, Ching-Yi [1 ]
Tsai, Cheng-Yu [1 ]
Lin, Shyh-Hsiang [1 ]
机构
[1] Taipei Med Univ, Grad Inst Nutr & Hlth Sci, Taipei, Taiwan
关键词
Soy; Isoflavone; Saponin; Triglyceride; Cholesterol;
D O I
10.3748/wjg.v11.i35.5549
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To assess the effects of soy protein, isoflavone, and saponin on liver and blood lipid in rats that consumed high-cholesterol diets. METHODS: High-cholesterol diets (1%) with or without soy material were fed to 6-wk-old male Sprague-Dawley rats for 8 wk. Blood lipids, liver lipids, glutamic oxaloacetic transaminase (GOT), and glutamic pyruvic transaminase (GPT) levels were measured. The in vitro bile acid-binding ability of soy materials was analyzed. RESULTS: The results of in vitro studies showed that soy protein isolate had a significantly higher bile acid-binding ability (8.4 +/- 0.8%) than soy saponin (3.1 +/- 0.7%) and isoflavone (1.3 +/- 0.4%, P<0.05). On the other hand, at the end of the experimental period, rats that consumed soy protein diets had lower GOT and GPT levels than rats that consumed casein under high-cholesterol diets. Rats that consumed soy protein also had lower total cholesterol (TC) levels in the liver than those that consumed casein under high-cholesterol diets. Rats that consumed the soy protein diet containing both saponin and isoflavone had lower hepatic TC level than those that consumed the soy protein diet without isoflavone alone. The effect of different types of proteins on triglyceride was not significant. CONCLUSION: Consumption of soy provided benefits to control lipid levels under high-cholesterol dieting conditions in this rat model of hypercholesterolemia. The major component that reduced hepatic TC was not saponin, but possibly isoflavone. (C) 2005 The WJG Press and Elsevier Inc. All rights reserved.
引用
收藏
页码:5549 / 5552
页数:4
相关论文
共 22 条
[1]
ANDERSON RL, 1995, J NUTR, V125, pS581, DOI 10.1093/jn/125.3_Suppl.581S
[2]
Soy protein, saponins and plasma cholesterol - Reply to Dr. David Oakenfull [J].
Arjmandi, BH .
JOURNAL OF NUTRITION, 2001, 131 (11) :2972-2972
[3]
CARROLL KK, 1991, J AM DIET ASSOC, V91, P820
[4]
Soy protein and cardiovascular disease - A statement for healthcare professionals from the Nutrition Committee of the AHA [J].
Erdman, JW .
CIRCULATION, 2000, 102 (20) :2555-2559
[5]
Gao Ying, 2002, Wei Sheng Yan Jiu, V31, P97
[6]
Differentially abundant mRNAs in rat liver in response to diets containing soy protein isolate [J].
Iqbal, MJ ;
Yaegashi, S ;
Ahsan, R ;
Lightfoot, DA ;
Banz, WJ .
PHYSIOLOGICAL GENOMICS, 2002, 11 (03) :219-226
[7]
EVIDENCE THAT POLYUNSATURATED LECITHIN INDUCES A REDUCTION IN PLASMA-CHOLESTEROL LEVEL AND FAVORABLE CHANGES IN LIPOPROTEIN COMPOSITION IN HYPERCHOLESTEROLEMIC RATS [J].
JIMENEZ, MA ;
SCARINO, ML ;
VIGNOLINI, F ;
MENGHERI, E .
JOURNAL OF NUTRITION, 1990, 120 (07) :659-667
[8]
Kanhal M. A., 2002, INT J FOOD SCI NUTR, V53, P381
[9]
Ethanol-extracted soy protein isolate does not modulate serum cholesterol in Golden Syrian hamsters: A model of postmenopausal hypercholesterolemia [J].
Lucas, EA ;
Khalil, DA ;
Daggy, BP ;
Arjmandi, BH .
JOURNAL OF NUTRITION, 2001, 131 (02) :211-214
[10]
THE ROLE OF SOY PRODUCTS IN REDUCING RISK OF CANCER [J].
MESSINA, M ;
BARNES, S .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (08) :541-546